Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nick Pavlakis, MD
Royal North Shore Hospital
Study Chair - Paul Mitchell, MD
Austin and Repatriation Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Cancer Centre, Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Sydney Haematology and Oncology Clinics
Hornsby, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Newcastle Mater Misericordiae Hospital
Waratah, New South Wales, Australia
- Prince Charles Hospital
Chermside, Queensland, Australia
- Nambour General Hospital
Nambour, Queensland, Australia
- Mater Hospital
South Brisbane, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- the Queen Elizabeth Hospital
Woodville, South Australia, Australia
- the Alfred Hospital
Prahran, Victoria, Australia
- Border Medical Oncology
Wodonga, Victoria, Australia
- Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2004
- Primary completion
- —
- Completion
- 31 Jul 2006
- Last update posted
- 27 Jun 2022
- Registered enrollment
- 100
- Registry id
- NCT00097851
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.